|
Volumn 29, Issue 1-2, 1997, Pages 534-538
|
Tacrolimus (FK506) is superior to cyclosporine in liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
FK 506 BINDING PROTEIN;
OKT 3;
TACROLIMUS;
APHASIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CONVULSION;
DRUG COST;
DRUG POTENCY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEADACHE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
PARESTHESIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
CONTROLLED CLINICAL TRIALS;
CYCLOSPORINE;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MULTICENTER STUDIES;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
|
EID: 0030905491
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00630-6 Document Type: Conference Paper |
Times cited : (35)
|
References (12)
|